MPM ASSET MANAGEMENT LLC - Q3 2021 holdings

$431 Million is the total value of MPM ASSET MANAGEMENT LLC's 9 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 22.2% .

 Value Shares↓ Weighting
ITOS SelliTeos Therapeutics, Inc.$88,849,000
-5.5%
3,290,711
-10.2%
20.59%
+17.8%
DYN  Dyne Therapeutics, Inc.$80,409,000
-22.8%
4,951,3030.0%18.64%
-3.8%
HOWL  Werewolf Therapeutics, Inc.$73,516,000
-1.6%
4,284,1720.0%17.04%
+22.7%
RPTX SellRepare Therapeutics, Inc.$58,847,000
-16.9%
2,242,636
-1.3%
13.64%
+3.6%
TCRR  TCR2 Therapeutics, Inc.$34,473,000
-48.1%
4,050,8650.0%7.99%
-35.4%
AMYT NewAmryt Pharma plc$32,160,0002,668,845
+100.0%
7.45%
ONCR  Oncorus, Inc.$26,614,000
-32.3%
2,849,4640.0%6.17%
-15.6%
HARP BuyHarpoon Therapeutics, Inc.$24,738,000
-43.0%
3,131,388
+0.0%
5.73%
-29.0%
RYTM  Rhythm Pharmaceuticals, Inc.$11,875,000
-33.3%
909,2580.0%2.75%
-16.9%
CHMA ExitChiasma, Inc.$0-5,736,296
-100.0%
-5.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Chiasma, Inc.24Q2 202119.8%
Aratana Therapeutics, Inc.24Q1 201926.8%
Conatus Pharmaceuticals, Inc.23Q1 20199.7%
Rhythm Pharmaceuticals, Inc.19Q2 202269.9%
Harpoon Therapeutics, Inc.19Q3 202331.9%
Syndax Pharmaceuticals, Inc.19Q3 202014.5%
Radius Health, Inc.17Q2 201876.4%
TCR2 Therapeutics, Inc.17Q1 202329.1%
Proteon Therapeutics, Inc.17Q4 20183.0%
EpiZyme, Inc.15Q4 201635.9%

View MPM ASSET MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR/A2023-09-07
13F-HR2023-08-14
42023-06-05
42023-05-24
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11

View MPM ASSET MANAGEMENT LLC's complete filings history.

Compare quarters

Export MPM ASSET MANAGEMENT LLC's holdings